17 results on '"Ren, Kai-Di"'
Search Results
2. Restoration of metal homeostasis: a potential strategy against neurodegenerative diseases
- Author
-
Zhang, Yi-Yue, Li, Xi-Sheng, Ren, Kai-Di, Peng, Jun, and Luo, Xiu-Ju
- Published
- 2023
- Full Text
- View/download PDF
3. Gene expression profiling of peripheral blood in patients with steroid-induced osteonecrosis of the femoral head.
- Author
-
Zhang, Cong-Min, Wei, Yuan, Tian, Xue-Ke, Ren, Kai-Di, and Yang, Jing
- Abstract
Aim: Steroid-induced osteonecrosis of the femoral head (SONFH) is a severe complication following glucocorticoid therapy. This study aimed to identify the differential mRNA expression and investigate the molecular mechanisms of SONFH. Materials & methods: RNA sequencing was performed in eight SONFH patients, five non-SONFH patients and five healthy individuals. Results: A total of 1555, 3997 and 5276 differentially expressed mRNAs existed between the following combinations: SONFH versus non-SONFH, SONFH versus healthy subjects and non-SONFH versus healthy subjects. Increased ISM1 expression might contribute to a high risk of SONFH through antiangiogenesis. Decreased FOLR3 expression might affect the metabolism of homocysteine, leading to avascular necrosis of the femoral head. KCNJ2, which plays a pivotal role in regulating bone development, was also deregulated. Conclusion:ISM1, FOLR3 and KCNJ2 might be related to the occurrence of SONFH. Summary points Background Steroid-induced osteonecrosis of the femoral head (SONFH) is a severe complication in clinical practice following extensive steroid treatment for various diseases. The occurrence of SONFH in patients using high-dose/long-term glucocorticoids has individual variability, which indicates that molecular biomarkers are urgently needed for the prevention of SONFH. Materials & methods RNA sequencing was performed to identify differentially expressed mRNAs in peripheral blood samples from eight SONFH patients, five non-SONFH patients and five healthy individuals. Gene Ontology and Kyoto Encyclopedia of Genes and Genomes pathway analyses were performed to analyze underlying mechanisms. Results A total of 1555, 3997 and 5276 differentially expressed mRNAs existed between the combinations SONFH versus non-SONFH group, SONFH versus healthy subjects and non-SONFH versus healthy subjects. Compared with the non-SONFH group, the most enriched Gene Ontology terms for the SONFH group were concentrated in dendrites, dendritic trees, voltage-gated calcium channel complexes, neutrophil degranulation, neutrophil-mediated immunity and neutrophil activation involved in the immune response membrane. Differentially expressed mRNAs were closely associated with ribosome, circadian entrainment and oxytocin signaling pathways in the comparison between SONFH and non-SONFH subjects based on Kyoto Encyclopedia of Genes and Genomes analysis. Of these top differentially expressed genes, we suggest that three key genes, ISM1, FOLR3 and KCNJ2, might be associated with the occurrence and development of SONFH. Conclusion Our results may provide novel insights into the pathogenesis of and intervention for SONFH. Large-scale studies and verification experiments are necessary to confirm the present results. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Mitophagy and Traumatic Brain Injury: Regulatory Mechanisms and Therapeutic Potentials.
- Author
-
Luan, Yi, Jiang, Lulu, Luan, Ying, Xie, Yi, Yang, Yang, and Ren, Kai-Di
- Published
- 2023
- Full Text
- View/download PDF
5. Beneficial effect of magnesium lithospermate B on cerebral ischemia–reperfusion injury in rats involves the regulation of miR-107/glutamate transporter 1 pathway
- Author
-
Yang, Zhong-Bao, Luo, Xiu-Ju, Ren, Kai-Di, Peng, Jing-Jie, Tan, Bin, Liu, Bin, Lou, Zheng, Xiong, Xiao-Ming, Zhang, Xiao-Jie, Ren, Xian, and Peng, Jun
- Published
- 2015
- Full Text
- View/download PDF
6. New Insight in HDACs: Potential Therapeutic Targets for the Treatment of Atherosclerosis.
- Author
-
Luan, Yi, Liu, Hui, Luan, Ying, Yang, Yang, Yang, Jing, and Ren, Kai-Di
- Subjects
CARDIOVASCULAR system ,DRUG target ,HISTONE deacetylase inhibitors ,ATHEROSCLEROSIS ,GENETIC transcription regulation ,HISTONES - Abstract
Atherosclerosis (AS) features include progressive hardening and reduced elasticity of arteries. AS is the leading cause of morbidity and mortality. An increasing amount of evidence showed that epigenetic modifications on genes serve are a main cause of several diseases, including AS. Histone deacetylases (HDACs) promote the deacetylation at lysine residues, thereby condensing the chromatin structures and further inhibiting the transcription of downstream genes. HDACs widely affect various physiological and pathological processes through transcriptional regulation or deacetylation of other non-histone proteins. In recent years, the role of HDACs in vascular systems has been revealed, and their effects on atherosclerosis have been widely reported. In this review, we discuss the members of HDACs in vascular systems, determine the diverse roles of HDACs in AS, and reveal the effects of HDAC inhibitors on AS progression. We provide new insights into the potential of HDAC inhibitors as drugs for AS treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
7. Ferroptosis and Acute Kidney Injury (AKI): Molecular Mechanisms and Therapeutic Potentials.
- Author
-
Feng, Qi, Yu, Xiaoyue, Qiao, Yingjin, Pan, Shaokang, Wang, Rui, Zheng, Bin, Wang, Hui, Ren, Kai-Di, Liu, Hui, and Yang, Yang
- Subjects
ACUTE kidney failure ,DIABETIC nephropathies ,RENAL cell carcinoma ,CELL death ,IRON overload ,URINARY organs - Abstract
Acute kidney injury (AKI), a common and serious clinical kidney syndrome with high incidence and mortality, is caused by multiple pathogenic factors, such as ischemia, nephrotoxic drugs, oxidative stress, inflammation, and urinary tract obstruction. Cell death, which is divided into several types, is critical for normal growth and development and maintaining dynamic balance. Ferroptosis, an iron-dependent nonapoptotic type of cell death, is characterized by iron overload, reactive oxygen species accumulation, and lipid peroxidation. Recently, growing evidence demonstrated the important role of ferroptosis in the development of various kidney diseases, including renal clear cell carcinoma, diabetic nephropathy, and AKI. However, the exact mechanism of ferroptosis participating in the initiation and progression of AKI has not been fully revealed. Herein, we aim to systematically discuss the definition of ferroptosis, the associated mechanisms and key regulators, and pharmacological progress and summarize the most recent discoveries about the role and mechanism of ferroptosis in AKI development. We further conclude its potential therapeutic strategies in AKI. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus.
- Author
-
Yang, Yang, Luan, Ying, Feng, Qi, Chen, Xing, Qin, Bo, Ren, Kai-Di, and Luan, Yi
- Subjects
TYPE 2 diabetes ,HISTONES ,HISTONE methyltransferases ,HISTONE demethylases ,HISTONE methylation ,EPIGENETICS ,DIABETES - Abstract
Diabetes mellitus is a global public health challenge with high morbidity. Type 2 diabetes mellitus (T2DM) accounts for 90% of the global prevalence of diabetes. T2DM is featured by a combination of defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. However, the pathogenesis of this disease is complicated by genetic and environmental factors, which needs further study. Numerous studies have demonstrated an epigenetic influence on the course of this disease via altering the expression of downstream diabetes-related proteins. Further studies in the field of epigenetics can help to elucidate the mechanisms and identify appropriate treatments. Histone methylation is defined as a common histone mark by adding a methyl group (-CH3) onto a lysine or arginine residue, which can alter the expression of downstream proteins and affect cellular processes. Thus, in tthis study will discuss types and functions of histone methylation and its role in T2DM wilsed. We will review the involvement of histone methyltransferases and histone demethylases in the progression of T2DM and analyze epigenetic-based therapies. We will also discuss the potential application of histone methylation modification as targets for the treatment of T2DM. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Emerging Role of Mitophagy in the Heart: Therapeutic Potentials to Modulate Mitophagy in Cardiac Diseases.
- Author
-
Luan, Yi, Luan, Ying, Feng, Qi, Chen, Xing, Ren, Kai-Di, and Yang, Yang
- Published
- 2021
- Full Text
- View/download PDF
10. Suppression of NADPH oxidase attenuates hypoxia-induced dysfunctions of endothelial progenitor cells.
- Author
-
Liu, Bin, Ren, Kai-Di, Peng, Jing-Jie, Li, Tao, Luo, Xiu-Ju, Fan, Chengming, Yang, Jin-Fu, and Peng, Jun
- Subjects
- *
HYPOXIA-inducible factors , *NADPH oxidase , *PROGENITOR cells , *HYPERTENSION , *CATALASE , *GALACTOSIDASES , *THERAPEUTICS - Abstract
NADPH oxidases (NOX) - derived reactive oxygen species (ROS) contribute to oxidative injury in hypoxia-induced pulmonary arterial hypertension. This study aims to evaluate the status of NOX in endothelial progenitor cells (EPCs) under hypoxic condition and to determine whether NOX inhibitors could attenuate hypoxia-induced dysfunctions of EPCs. EPCs were isolated from peripheral blood of SD rats and subjected to hypoxia (O 2 /N 2 /CO 2 , 1/94/5) for 24 h. The cells were collected for β-galactosidase or Hoechst staining, or for functional analysis (migration, adhesion and tube formation). The NOX expression, activity and H 2 O 2 content in EPCs were measured. The results showed that hypoxia treatment promoted EPC senescence and apoptosis, accompanied by the deteriorated functions of EPCs (the reduced abilities in adhesion, migration and tube formation), as well as an increase in NOX2 and NOX4 expression, NOX activity and H 2 O 2 production, these phenomena were attenuated by NOX inhibitors. Furthermore, administration of catalase could also improve the functions of hypoxia-treated EPCs. Based on these observations, we conclude that NOX-derived ROS contributes to the dysfunctions of EPCs under hypoxic condition. Thus, suppression of NOX may provide a novel strategy to improve endothelial functions in hypoxia-relevant diseases. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
11. Mitochondrial E3 ubiquitin ligase 1: A key enzyme in regulation of mitochondrial dynamics and functions.
- Author
-
Peng, Jun, Ren, Kai-Di, Yang, Jie, and Luo, Xiu-Ju
- Subjects
- *
UBIQUITIN ligases , *MITOCHONDRIAL proteins , *MITOCHONDRIAL physiology , *CYTOPLASM , *UBIQUITINATION , *MITOFUSIN 1 protein - Abstract
Mitochondrial E3 ubiquitin ligase 1 (Mul1) is a multifunctional mitochondrial membrane protein with its RING domain exposed to the cytoplasm. On the one hand, Mul1 functions as a ubiquitin-ligase to ubiquitinate a bunch of signal molecules, such as mitofusin2 (Mfn2), Akt, p53 and ULK1, through its RING finger domain, leading to proteins degradation. On the other hand, Mul1 acts as a small ubiquitin-like modifiers (SUMO) E3 ligase to sumoylate certain proteins, such as dynamin-related protein 1 (Drp1), enhancing protein stabilization. Through the dual functions of ubiquitination and SUMOylation, Mul1 involves in regulation of many physiological and pathological processes, such as mitochondrial dynamics, cell growth, apoptosis and mitophagy. In addition, Mul1 can also directly activate or interact with some proteins, such as NF-κB and JNK, to take part in the regulation of cellular apoptosis. This review summarizes recent progress in relevant studies on the physiological and pathological functions of Mul1 and pays special attention to its role in regulation of mitochondrial dynamics. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. Mitochondrial E3 ubiquitin ligase 1 promotes brain injury by disturbing mitochondrial dynamics in a rat model of ischemic stroke.
- Author
-
Ren, Kai-Di, Liu, Wei-Ning, Tian, Jing, Zhang, Yi-Yue, Peng, Jing-Jie, Zhang, Di, Li, Nian-Sheng, Yang, Jie, Peng, Jun, and Luo, Xiu-Ju
- Subjects
- *
BRAIN injuries , *MITOCHONDRIAL proteins , *CHIMERIC proteins , *STROKE , *CYTOCHROME c , *UBIQUITIN ligases , *UBIQUITINATION - Abstract
Mitochondrial dysfunctions contribute to brain injury in ischemic stroke while disturbance of mitochondrial dynamics results in mitochondrial dysfunction. Mitochondrial E3 ubiquitin ligase 1 (Mul1) involves in regulation of mitochondrial fission and fusion. This study aims to explore whether Mul1 contributes to brain injury in ischemic stroke and the underlying mechanisms. First, a rat ischemic stroke model was established by middle cerebral artery occlusion (MCAO), which showed ischemic injuries (increase in neurological deficit score and infarct volume) and upregulation of Mul1 in brain tissues. Next, Mul1 siRNAs were injected intracerebroventricularly to knockdown Mul1 expression, which evidently attenuated brain injuries (decrease in neurological deficit score, infarct volume and caspase-3 activity), restored mitochondrial dynamics and functions (decreases in mitochondrial fission and cytochrome c release while increase in ATP production), and restored protein levels of dynamin-related protein 1 (Drp1, a mitochondrial fission protein) and mitofusin2 (Mfn2, a mitochondrial fusion protein) through suppressing their sumoylation and ubiquitination, respectively. Finally, PC12 cells were cultured under hypoxic condition to mimic the ischemic stroke. Consistently, knockdown of Mul1 significantly reduced hypoxic injuries (decrease in apoptosis and LDH release), restored protein levels of Drp1 and Mfn2, recovered mitochondrial dynamics and functions (decreases in mitochondrial fission, mitochondrial membrane potential, reactive oxygen species production and cytochrome c release while increase in ATP production). Based on these observations, we conclude that upregulation of Mul1 contributes to brain injury in ischemic stroke rats and disturbs mitochondrial dynamics through sumoylation of Drp1 and ubiquitination of Mfn2. Image 1 [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
13. Broadening Horizons: Exploring the Cathepsin Family as Therapeutic Targets for Alzheimer's Disease.
- Author
-
Liu XH, Liu XT, Wu Y, Li SA, Ren KD, Cheng M, Huang B, Yang Y, and Liu PP
- Abstract
Alzheimer's disease (AD) is an intricate neurodegenerative disorder characterized by the accumulation of misfolded proteins, including beta-amyloid (Aβ) and tau, leading to cognitive decline. Despite decades of research, the precise mechanisms underlying its onset and progression remain elusive. Cathepsins are a family of lysosomal enzymes that play vital roles in cellular processes, including protein degradation and regulation of immune responses. Emerging evidence suggests that cathepsins may be involved in AD pathogenesis. Cathepsins can influence the activation of microglia and astrocytes, the resident immune cells in the brain. However, cathepsin dysfunction may lead to the accumulation of misfolded proteins, notably Aβ and tau. In addition, dysregulated cathepsin activity may induce an exaggerated immune response, promoting chronic inflammation and neuronal dysfunction in patients with AD. By unraveling the classification, functions, and roles of cathepsins in AD's pathogenesis, this review sheds light on their intricate involvement in this devastating disease. Targeting cathepsin activity could be a promising and novel approach for mitigating the pathological processes that contribute to AD, providing new avenues for its treatment and prevention.
- Published
- 2024
- Full Text
- View/download PDF
14. Dipsacoside B Exerts a Beneficial Effect on Brain Injury in the Ischemic Stroke Rat through Inhibition of Mitochondrial E3 Ubiquitin Ligase 1.
- Author
-
Ren KD, Peng ZM, Tian J, Peng YW, Zhang YY, Zhang XJ, Hu ZY, Luo XJ, and Peng J
- Subjects
- Adenosine Triphosphate metabolism, Animals, Apoptosis, Hypoxia, Mitochondria metabolism, Mitochondrial Proteins metabolism, Oleanolic Acid analogs & derivatives, PC12 Cells, Rats, Rats, Sprague-Dawley, Saponins, Ubiquitin-Protein Ligases metabolism, Brain Injuries, Ischemic Stroke
- Abstract
Background: Upregulation of mitochondrial E3 ubiquitin ligase 1 (Mul1) contributes to brain injury in ischemic stroke due to disturbance of mitochondrial dynamics, and bioinformatics analysis predicts that Mul1 is a potential target of Dipsacoside B., Objective: The aim of the study was to explore whether Dipsacoside B can exert a beneficial effect on brain injury in the ischemic stroke rat via targeting Mul1., Methods: The SD rat brains or PC12 cells were subjected to 2 h-ischemia or 8 h-hypoxia plus 24 h-reperfusion or 24 h-reoxygenation to establish the ischemic stroke rat model in vivo or in vitro, which were treated with Dipsacoside B at different dosages. The brain or PC12 cell injury, relevant protein levels and mitochondrial functions were measured by methods of biochemistry, flow cytometry or Western blot., Results: The neurological dysfunction and brain injury (such as infarction and apoptosis) observed in the ischemic stroke rats were accompanied by increases in Mul1 and Dynamin-related protein 1 (Drp1) levels along with decreases in mitofusin 2 (Mfn2) level and ATP production. These effects were attenuated by Dipsacoside B. Consistently, cell injury (necroptosis and apoptosis) occurred in the PC12 cells exposed to hypoxia concomitant with the upregulation of Mul1 and Drp1 along with downregulation of Mfn2 and mitochondrial functions (such as increases in reactive oxygen species production and mitochondrial fission and decreases in mitochondrial membrane potential and ATP production).These phenomena were reversed in the presence of Dipsacoside B., Conclusion: Dipsacoside B can protect the rat brain against ischemic injury via inhibition of Mul1 due to the improvement of mitochondrial function., (Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.)
- Published
- 2022
- Full Text
- View/download PDF
15. Mitochondrial Dynamics: Pathogenesis and Therapeutic Targets of Vascular Diseases.
- Author
-
Luan Y, Ren KD, Luan Y, Chen X, and Yang Y
- Abstract
Vascular diseases, particularly atherosclerosis, are associated with high morbidity and mortality. Endothelial cell (EC) or vascular smooth muscle cell (VSMC) dysfunction leads to blood vessel abnormalities, which cause a series of vascular diseases. The mitochondria are the core sites of cell energy metabolism and function in blood vessel development and vascular disease pathogenesis. Mitochondrial dynamics, including fusion and fission, affect a variety of physiological or pathological processes. Multiple studies have confirmed the influence of mitochondrial dynamics on vascular diseases. This review discusses the regulatory mechanisms of mitochondrial dynamics, the key proteins that mediate mitochondrial fusion and fission, and their potential effects on ECs and VSMCs. We demonstrated the possibility of mitochondrial dynamics as a potential target for the treatment of vascular diseases., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Luan, Ren, Luan, Chen and Yang.)
- Published
- 2021
- Full Text
- View/download PDF
16. The Diagnostic Value of Circulating Brain-specific MicroRNAs for Ischemic Stroke.
- Author
-
Yang ZB, Li TB, Zhang Z, Ren KD, Zheng ZF, Peng J, and Luo XJ
- Subjects
- Biomarkers blood, Brain diagnostic imaging, Brain Ischemia blood, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prospective Studies, ROC Curve, Real-Time Polymerase Chain Reaction, Brain metabolism, Brain Ischemia diagnosis, MicroRNAs blood
- Abstract
Objective Circulating microRNAs have been recognized as promising biomarkers for various diseases. The aim of the present study was to explore the potential role of circulating miR-107, miR-128b and miR-153 as non-invasive biomarkers in the diagnosis of ischemia stroke. Methods One hundred and fourteen ischemic stroke patients (61±11.3 years old) and 58 healthy volunteers (56±3.9 years old) matched for age and sex were enrolled in this study. Total RNA was isolated from plasma with TRIzol reagent. The circulating microRNAs levels were measured by quantitative real-time polymerase chain reaction. Results The circulating levels of miR-107, miR-128b and miR-153 significantly increased 2.78-, 2.13- and 1.83-fold in ischemia stroke patients in comparison to the healthy volunteers, respectively. Receiver operating characteristic (ROC) curves were analyzed using the SPSS software program and revealed the areas under the curve for circulating miR-107, miR-128b and miR-153 to be 0.97, 0.903 and 0.893 in ischemia stroke patients in comparison to healthy volunteers, respectively. The levels of circulating miR-107, miR-128b and miR-153 therefore positively correlated with the severity of stroke as defined by NIHSS classes. Conclusion Our results suggest that circulating miR-107, miR-128b and miR-153 might be used as potential novel non-invasive biomarkers for the diagnosis of ischemia stroke. However, future prospective trials in large-sized patient cohorts are needed before drawing any definitive conclusions.
- Published
- 2016
- Full Text
- View/download PDF
17. Salviaolate Protects Rat Brain from Ischemia-Reperfusion Injury through Inhibition of NADPH Oxidase.
- Author
-
Lou Z, Ren KD, Tan B, Peng JJ, Ren X, Yang ZB, Liu B, Yang J, Ma QL, Luo XJ, and Peng J
- Subjects
- Animals, Antioxidants therapeutic use, Benzoxazoles pharmacology, Brain drug effects, Brain enzymology, Cells, Cultured, China, Disease Models, Animal, Drugs, Chinese Herbal chemistry, Male, Rats, Rats, Sprague-Dawley, Triazoles pharmacology, Rosmarinic Acid, Benzofurans therapeutic use, Brain Ischemia prevention & control, Cinnamates therapeutic use, Depsides therapeutic use, Drugs, Chinese Herbal therapeutic use, NADPH Oxidases antagonists & inhibitors, Neuroprotective Agents therapeutic use, Reperfusion Injury prevention & control, Salvia miltiorrhiza chemistry
- Abstract
Salviaolate is a group of depside salts isolated from Danshen (a traditional Chinese herbal medicine), with ≥ 85 % of magnesium lithospermate B. This study aims to investigate whether salviaolate is able to protect the rat brain from ischemia/reperfusion injury and the underlying mechanisms. Rats were subjected to 2 h of cerebral ischemia and 24 h of reperfusion to establish an ischemia/reperfusion injury model. The neuroprotective effects of salviaolate at different dosages were evaluated. A dosage (25 mg/kg) was chosen to explore the neuroprotective mechanisms of salviaolate. Neurological function, infarct volume, cellular apoptosis, nicotinamide adenine dinucleotide phosphate-oxidase activity, and H2O2 content were measured. In a nerve cell model of hypoxia/reoxygenation injury, magnesium lithospermate B was applied. Cellular apoptosis, lactate dehydrogenase, nicotinamide adenine dinucleotide phosphate-oxidase activity, and H2O2 content were examined. Ischemia/reperfusion treatment significantly increased the neurological deficit score, infarct volume, and cellular apoptosis accompanied by the elevated nicotinamide adenine dinucleotide phosphate-oxidase activity and H2O2 content in the rat brains. Administration of salviaolate reduced ischemia/reperfusion-induced cerebral injury in a dose-dependent manner concomitant with a decrease in nicotinamide adenine dinucleotide phosphate-oxidase activity and H2O2 production. Magnesium lithospermate B (20 mg/kg) and edaravone (6 mg/kg, the positive control) achieved the same beneficial effects as salviaolate did. In the cell experiments, the injury (indicated by apoptosis ratio and lactate dehydrogenase release), nicotinamide adenine dinucleotide phosphate-oxidase activity and H2O2 content were dramatically increased following hypoxia/reoxygenation, which were attenuated in the presence of magnesium lithospermate B (10(-5) M), VAS2870 (nicotinamide adenine dinucleotide phosphate-oxidase inhibitor), or edaravone (10(-5) M). The results suggest that salviaolate is able to protect the brain from ischemia/reperfusion oxidative injury, which is related to the inhibition of nicotinamide adenine dinucleotide phosphate-oxidase and a reduction of reactive oxygen species production., (Georg Thieme Verlag KG Stuttgart · New York.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.